414123001: Erlotinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\...

\Epidermal growth factor receptor inhibitor\Erlotinib (substance)

\Protein-tyrosine kinase inhibitor\Erlotinib (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Epidermal growth factor receptor inhibitor\Erlotinib (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Substance with ether structure\Erlotinib (substance)

\Organic cyclic compound\Heterocyclic compound\Quinazoline (substance)\Erlotinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2005. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2531730010 Erlotinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2535285016 Erlotinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

60081000195112 erlotinib it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

809361000172115 erlotinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

75461000195113 Erlotinib de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erlotinib (substance)	Is a	Quinazoline (substance)	true	Inferred relationship	Some
Erlotinib (substance)	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Erlotinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Erlotinib (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Erlotinib (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Erlotinib (substance)	Is a	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some
Erlotinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some
Erlotinib (substance)	Is a	éther	false	Inferred relationship	Some
Erlotinib (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing erlotinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erlotinib (substance)	Inferred relationship	Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erlotinib (substance)	Inferred relationship	Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erlotinib (substance)	Inferred relationship	Some
Erlotinib hydrochloride (substance)	Is a	False	Erlotinib (substance)	Inferred relationship	Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erlotinib (substance)	Inferred relationship	Some	1
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Erlotinib (substance)	Inferred relationship	Some
Erlotinib only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erlotinib (substance)	Inferred relationship	Some	1
Erlotinib only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erlotinib (substance)	Inferred relationship	Some	1

Reference Sets